M. Mandelboim

This study shows a bispecific antibody targeting both influenza virus hemagglutinin and neuraminidase improves antiviral activity by blocking infection and preventing virus release.

This study investigates how mutations at position 681 of the SARS-CoV-2 spike protein affect viral fusogenicity and syncytia formation across variants.

This study compares SARS-CoV-2 Omicron replication in human lung and nasal tissues to other variants, finding restricted replication in lungs and a stronger interferon response.

This study evaluates the neutralization potency of four SARS-CoV-2 mAbs against spike mutations and two variants of concern, finding that MD65 and BL6 retain effectiveness against B.1.1.7 and B.1.351.

This study uses CRISPR screens to identify host factors critical for SARS-CoV-2 infection, finding GATA6 as a key modulator of ACE2 expression and viral entry.

This study uses transcriptomic analysis to identify cellular pathway changes in HCoV-229E-infected cells and links APOBEC3B activity to genomic mutations in SARS-CoV-2.

This study shows influenza virus inhibits RSV infection through a two-wave upregulation of IFIT proteins, observed in both in vitro and in vivo models.